Nasiri Muhammad Iqbal, Naqvi Syed Baqir-Shyum, Zaidi Aamir Ali, Saeed Rehana, Raza Ghazala
Department of Pharmaceutics, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.
Pak J Pharm Sci. 2013 Mar;26(2):415-9.
The aim of this study is to evaluate the susceptibility and resistance pattern of clinical isolates causing different types of infections and to compare the efficacy of antibiotics namely levofloxacin and cefepime. The in-vitro antibacterial activity and resistance patterns of these two well known antibiotics were studied and compared using disk diffusion method. For this, one hundred clinical isolates comprising of Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa were collected from different local pathological laboratories and hospitals. Escherichia coli (17.95% against cefepime and 30.77% against levofloxacin), Staphylococcus aureus (30% against cefepime and 46.66% against levofloxacin) and Pseudomonas aeruginosa (23.53% against cefepime and 35.29% against levofloxacin) were found resistant against the studied antibiotics which show that cefepime is more effective than levofloxacin. In case of Klebsiella pneumoniae, resistance was 42.85% against cefepime and 35.71% against levofloxacin thereby showing that levofloxacin is more effective than cefepime. Concluded that the clinical isolates collected were susceptible to both the antibiotics but the microbial resistance against these antibiotics is increasing in our population which is alarming. Therefore, it is recommended the physicians may prescribe these antibiotics unless no other substitute is available in clinical practice.
本研究的目的是评估引起不同类型感染的临床分离株的药敏和耐药模式,并比较左氧氟沙星和头孢吡肟这两种抗生素的疗效。使用纸片扩散法研究并比较了这两种知名抗生素的体外抗菌活性和耐药模式。为此,从不同的当地病理实验室和医院收集了100株临床分离株,包括大肠杆菌、金黄色葡萄球菌、肺炎克雷伯菌和铜绿假单胞菌。发现大肠杆菌(对头孢吡肟耐药率为17.95%,对左氧氟沙星耐药率为30.77%)、金黄色葡萄球菌(对头孢吡肟耐药率为30%,对左氧氟沙星耐药率为46.66%)和铜绿假单胞菌(对头孢吡肟耐药率为23.53%,对左氧氟沙星耐药率为35.29%)对所研究的抗生素耐药,这表明头孢吡肟比左氧氟沙星更有效。在肺炎克雷伯菌中,对头孢吡肟的耐药率为42.85%,对左氧氟沙星的耐药率为35.71%,从而表明左氧氟沙星比头孢吡肟更有效。得出结论,所收集的临床分离株对这两种抗生素均敏感,但在我们的人群中对这些抗生素的微生物耐药性正在增加,这令人担忧。因此,建议医生在临床实践中除非没有其他替代品,否则可开具这些抗生素。